For patients with diabetes, the days after hospital discharge can be as risky as the days leading up to admission. Clinicians ...
The Mumbai-based drugmaker, in a regulatory filing, said it has the rights to distribute and promote Yurpeak, the second anti ...
Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care ...
Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...
Aeroflow Health, a pioneering healthcare company that leverages cutting-edge technology to support the delivery of medical products and services, announced a new partnership with Molina Healthcare of ...
The nurse and diabetes educator was named the NT News Territory Leader of the Year, brought to you by Sitzler at an awards ...
Mbagathi Hospital is set for a breakthrough in diabetes care following the commencement of construction of a fully equipped diabetes clinic, Chief Executive Officer Alexander Irungu announced.
NYC Health + Hospitals/North Central Bronx was recently recognized with a triple achievement by the American Heart ...
Magnesium and potassium are important minerals for health, and many people don't get enough of either. Taking both with food can improve absorption.
Pune: In a significant move toward transforming amputee rehabilitation in the country, Vice Admiral Arti Sarin, director ...
Because it causes tissue damage and tissue death in the legs, feet, and toes, PAD is implicated in 150,000 lower-limb ...
Asianet Newsable on MSN
Cipla launches tirzepatide drug Yurpeak for diabetes, obesity in India
Cipla has launched Yurpeak (tirzepatide), a once-weekly injectable for adults with obesity and type 2 diabetes. As the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results